WOLF GREENFIELD WEBINAR: CRISPR Cas9 and the IP Landscape for a Revolutionary New Technology - Webcast Now Available

June 23, 2014 9:30 AM - 3:30 PM ET

On February 5, 2014, Wolf Greenfield attorneys Patricia Granahan and Chelsea Loughran presented a webinar titled, "CRISPR/Cas-9 and the IP Landscape for a Revolutionary New Technology."

CRISPR/Cas-9 is a new genomic editing system that has the potential to revolutionize basic biomedical research and, possibly, the treatment of genetic disease. The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) system utilizes guide RNA as a gene-homing mechanism and a Cas-9 nuclease to cut targeted DNA. As such, it drastically reduces the time-to-results and design complexity associated with existing genomic editing tools.

Given CRISPR’s simplicity and widespread applicability in biomedical research, scientists and university technology licensing officers are understandably asking about intellectual property rights and access to this technology, both today and looking forward.

A webcast may be viewed here.